Upcoming webinar: Speech as a biomarker in Ataxia: What can it tell us & how should we use it?

Redenlab CSO, Adam Vogel, will be presenting at the upcoming joint webinar with the European Reference Network for rare or low prevalence complex diseases, Neurological Diseases (ERN-RND), Neuromuscular Dieseases (ERN EURO-NMD), and European Academy of Neurology. The subject of the webinar is Speech as a biomarker in Ataxia: What can it tell us & how should we use it?

Related Post

2023 Digital Health Innovation in Clinical Trials, Drug Development and Mobile Healthcare: June 6 – 7, 2023

  • Posted on 4 March, 2023
    Join World BI for its 23rd rebranded edition of the Digital Health Innovation in Clinical Trials, Drug Development and Mobile...
    Read more

    2022 Kabuki Syndrome Foundation Virtual Conference: October 26 – 27, 2022

    • Posted on 17 November, 2022
      The 4th Annual Kabuki Syndrome Foundation Research Conference to be held virtually on Friday, November 4, 2022. The Annual Conference...
      Read more

      20th Clinical Trials Innovation Programme: October 26 – 27, 2022

      • Posted on 21 October, 2022
        Join World BI and Redenlab for the 20th Clinical Trials Innovation Programme, to learn from experts in the drug development...
        Read more